Blocking the CD47-SIRPα Axis enhances Tafasitamab-mediated phagocytosis

被引：0

作者：

Biedermann, A. ^{[1
]}

Mangelberger-Eberl, D. ^{[2
]}

Mougiakakos, D. ^{[3
]}

Buettner-Herold, M. ^{[4
]}

Patra-Kneuer, M. ^{[2
]}

Flamann, C. ^{[1
]}

Kellner, C. ^{[5
]}

Peipp, M. ^{[6
]}

Altmeyer, S. ^{[7
]}

Bittenbring, J. ^{[7
]}

Augsberger, C. ^{[2
]}

Landgraf, K. ^{[2
]}

Ilieva-Babinsky, K. ^{[2
]}

Hasskamp, S. ^{[8
,9
]}

Beier, F. ^{[10
]}

Lischer, C. ^{[11
]}

Vera, J. ^{[11
]}

Voelkl, S. ^{[1
]}

Jacobs, B. ^{[1
]}

Steidl, S. ^{[2
]}

Heitmueller, C. ^{[2
]}

Mackensen, A. ^{[1
]}

Bruns, H. ^{[1
]}

机构：

[1] Friedrich Alexander Univ Erlangen Nurnberg, Dept Internal Med Hematol & Oncol 5, Erlangen, Germany

[2] MophoSys AG, Munich, Germany

[3] Otto von Guericke Univ, Dept Hematol & Oncol, Magdeburg, Germany

[4] Friedrich Alexander Univ Erlangen Nurnberg, Dept Nephropathol, Erlangen, Germany

[5] Ludwig Maximilians Univ Munchen, Univ Hosp, Div Transfus Med Cell Therapeut & Haemostaseol, Munich, Germany

[6] Univ Hosp Schleswig Holstein, Dept Internal Med 2, Kiel, Germany

[7] Saarland Univ, Med Klin 1, Med Sch, Homburg, Germany

[8] Friedrich Alexander Univ Erlangen Nurnberg, Erlangen, Germany

[9] Inst Human Genet, Erlangen, Germany

[10] RWTH Med Sch, Dept Oncol Hematol & Stem Cell Transplantat, Aachen, Germany

[11] Friedrich Alexander Univ Erlangen Nurnberg, Dept Dermatol, Erlangen, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P762

引用

页码：269 / 269

页数：1

共 50 条

[1] Blocking the CD47-Sirpa Axis Enhances Tafasitamab-Mediated Phagocytosis
Biedermann, Alexander
Mangelberger-Eberl, Doris
Mougiakakos, Dimitrios
Buettner-Herold, Maike
Flamann, Cindy
Kellner, Christian
Altmeyer, Sarah
Bittenbring, Joerg
Augsberger, Christian
Patra-Kneuer, Maria
Landgraf, Karin
Ilieva-Babinsky, Kristina
Haskamp, Stefan
Beier, Fabian
Voelkl, Simon
Pallasch, Christian
Jacobs, Benedikt
Steidl, Stefan
Heitmueller, Christina
Mackensen, Andreas
Bruns, Heiko
BLOOD, 2022, 140 : 9292 - 9293
[2] Blocking CD47-SIRPα Signal Axis as Promising Immunotherapy in Ovarian Cancer
Luo, Xukai
Shen, Yini
Huang, Wu
Bao, Yiting
Mo, Jiahang
Yao, Liangqing
Yuan, Lei
CANCER CONTROL, 2023, 30
[3] CD47-SIRPα regulates Fcγ and complement receptor-mediated phagocytosis
Oldenborg, PA
Lindberg, FP
Gresham, HD
MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 461A - 461A
[4] The CD47-SIRPα axis is a promising target for cancer immunotherapies
Hao, Yu
Zhou, Xinxuan
Li, Yiling
Li, Bolei
Cheng, Lei
INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 120
[5] The CD47-SIRPα Immune Checkpoint
Logtenberg, Meike E. W.
Scheeren, Ferenc A.
Schumacher, Ton N.
IMMUNITY, 2020, 52 (05) : 742 - 752
[6] A novel therapeutic approach for glioblastoma: blocking CD47-SIRPα axis alone or combined with autophagy inhibitor
Chen, Wei
Luan, Jingyun
ANNALS OF ONCOLOGY, 2018, 29
[7] Blockade of the CD47-SIRPα axis: a promising approach for cancer immunotherapy
Uger, Robert
Johnson, Lisa
EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (01) : 5 - 8
[8] Recent Advances of Tumor Therapy Based on the CD47-SIRP? Axis
Wang, Yuchen
Zhao, Chenxuan
Liu, Yang
Wang, Chao
Jiang, Haojie
Hu, Yiqiao
Wu, Jinhui
MOLECULAR PHARMACEUTICS, 2022, 19 (05) : 1273 - 1293
[9] miR-378a Modulates Macrophage Phagocytosis and Differentiation through Targeting CD47-SIRPα Axis in Atherosclerosis
Chen, Wenna
Li, Ximing
Wang, Junyan
Song, Nan
Zhu, Aisong
Jia, Lianqun
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2019, 90 (01)
[10] The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
Matlung, Hanke L.
Szilagyi, Katka
Barclay, Neil A.
van den Berg, Timo K.
IMMUNOLOGICAL REVIEWS, 2017, 276 (01) : 145 - 164

← 1 2 3 4 5 →